Actively Recruiting
REBOA in Nontraumatic OHCA
Led by Seoul National University Hospital · Updated on 2025-01-28
234
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
S
Seoul National University Hospital
Lead Sponsor
F
Far Eastern Memorial Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators propose a multicenter randomized controlled trial in South Korea and Taiwan to observe the clinical effects of REBOA on nontraumatic out-of-hospital-cardiac-arrest (OHCA) patients. While REBOA has been traditionally used in trauma for hemorrhage control, it has also shown promising results in nontraumatic cardiac arrests by rerouting circulation to increase perfusion in the coronary and brain.
CONDITIONS
Official Title
REBOA in Nontraumatic OHCA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult nontraumatic out-of-hospital cardiac arrest (OHCA)
- Witnessed cardiac arrest
- Arrival at emergency room from 9 AM to 5 PM in South Korea or 8 AM to 8 PM in Taiwan
- Age between 20 and 80 years old
You will not qualify if you...
- Age below 20 years or over 80 years
- Traumatic cardiac arrest
- Unwitnessed cardiac arrest
- Pregnancy
- Achieved return of spontaneous circulation (ROSC) upon emergency department arrival
- Pre-cardiac arrest cerebral performance category of 3-4
- Evidence of cardiac arrest due to bleeding such as gastrointestinal bleeding
- Suspected or known aortic disease including dissection, intramural hematoma, or aneurysm
- Legal representative requested termination of resuscitation before enrollment
- Declared dead at the scene before randomization
- Meeting criteria for extracorporeal cardiopulmonary resuscitation (ECPR) and decision to perform ECPR
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul National Univeristy Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620
Actively Recruiting
Research Team
H
Hee Eun Kim
CONTACT
D
Dong Hyun Jang
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here